SVM Dinner Symposium
Lymphedema: The Other Vascular Disease
Wednesday Dinner Symposium Added to the SVM Annual Meeting Program
SVM has added a dinner symposium, "Lymphedema: The Other Vascular Disease" to the SVM Annual Meeting program on Wednesday, May 13, from 7 to 9 p.m. The dinner presentation is provided through support from Tactile Systems Technology, Inc.
All paid registrants are welcome to attend. Please confirm your attendance at the dinner using this link.
The SVM registration desk will open on Wednesday, May 13 at 4 p.m. so you can pick-up badges and other meeting materials.
Dinner Program Details
The Other Vascular Disease
Lymphedema is an incurable, debilitating condition that affects an estimated 170 million people worldwide. The disease can result from genetic abnormalities, infections, after surgery, radiation, or traumatic injury to the lymphatic system. The most common cause of lymphedema in the United States is the treatment of cancer, with more than 3.3 million cancer survivors who are at a lifetime risk for the disease. Although major advances have been made in cancer prevention and treatment, minimal attention has been given to lymphedema.
After many decades of relative neglect and lack of recognition, our knowledge of the lymphatic system and its role in lymphedema and other related diseases has expanded exponentially. The evening symposium will review key concepts and findings that shed light on these new developments, and will provide current views regarding the biology, diagnosis and treatment of lymphedema.
Speakers and Topics
David C. Zawieja, PhD, Professor and Associate Head, Department of Systems Biology and Translational Medicine, Director Division of Lymphatic Biology, Cardiovascular Research Institute, Texas A&M Health Science Center College of Medicine, Temple, TX
Contractile Physiology of Lymphatics
The lymphatic system is a specialized transport system that serves important roles in body fluid and macromolecular homeostasis, lipid absorption/transport and immune cell trafficking from the interstitium to the lymph nodes. The presentation will review the underlying physiological principles that govern the generation and regulation of lymph flow throughout the lymphatic network, and describe the roles of the specialÂized lymphatic pumps, valves and conduits. Examples of problems in lymph transport and how these relate to disease processes also will be reviewed.
Stanley G. Rockson, M.D., Allan and Tina Neill Professor of Lymphatic Research and Medicine, Chief of Consultative Cardiology, Falk Cardiovascular Research Center, Stanford University School of Medicine, Stanford, CA
The Unique Biology of Lymphatic Edema
The lymphatic vasculature is composed of a network of vessels that is essential both to fluid homeostasis and to the mediation of regional immune responses. In health, the lymphatic vasculature possesses the requisite transport capacity to accommodate the fluid load placed upon it. The most readily recognizable attribute of lymphatic vascular incompetence is the presence of characteristic swelling of tissues, called lymphedema, which arises as a consequence of insufficient lymph transport. Lymphedema can result from either primary or acquired (secondary) disorders. This presentation will review the latest findings on the biology, pathophysiology, classification, natural history, differential diagnosis and treatment of lymphedema.
Cindy Felty, R.N., C.N.P., C.W.S., Director of the Vascular Ulcer/Wound Healing Clinic, Assistant Professor of Medicine, Mayo Clinic College of Medicine, Mayo Clinic, Rochester, Minnesota
Lymphedema: Quality of Life Impact
Lymphedema and its treatment can have a significant deleterious impact on a patient's emotional, functional and psychological wellbeing. These quality-of-life challenges are often not addressed by healthcare professionals, as they remain understudied and underreported by both patients and physicians. This presentation will summarize recent research to increase awareness and enhance clinician ability to identify and manage lymphedema toward achieving positive patient outcomes.
Symposium proceedings will be published in the journal, Vascular Medicine.